chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymphnode under my left arm pit; A very sore neck and shoulders; A very sore neck and shoulders; I began getting random and severe hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Jun2021 (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Broccoli" (unspecified if ongoing); "known allergies: chocolate" (unspecified if ongoing); "known allergies: plumbs" (unspecified if ongoing); "known allergies: wheat" (unspecified if ongoing); "known allergies: bakers yeast" (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]; TYLENOL. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: May2021, when the patient was 42 years old, for COVID-19 Immunization, reaction(s): "a very sore neck and shoulders", "swollen lymphnode under my left arm pit", "a very sore neck and shoulders". The following information was reported: LYMPHADENOPATHY (non-serious) with onset Jun2021, outcome "not recovered", described as "Swollen lymphnode under my left arm pit"; NECK PAIN (non-serious), ARTHRALGIA (non-serious) all with onset Jun2021, outcome "not recovered" and all described as "A very sore neck and shoulders"; URTICARIA (non-serious) with onset Jun2021, outcome "not recovered", described as "I began getting random and severe hives". The events "swollen lymphnode under my left arm pit", "a very sore neck and shoulders", "a very sore neck and shoulders" and "i began getting random and severe hives" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy, neck pain, arthralgia, urticaria. The lot number for bnt162b2 was not provided and will be requested during follow up.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. covid test type post vaccination=Nasal Swab (covid test date=Jul2021) covid test result=Negative, covid test type post vaccination=Nasal Swab (covid test date=Jun2021) covid test result=Negative, covid test type post vaccination=Nasal Swab (covid test date=Aug2021) covid test result=Negative.
This report was received from Pfizer and was assigned (Manufacturer Control # 2015071520) for PREVNAR 13. This was originally reported by a physician. This spontaneous repot refers to a 80 year old female patient with no relevant medical conditions who on approximately 24-FEB-2007 (reported as "about 8 years ago"), the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route, lot # and expiration date were not provided). The physician did not known about other medications patient was taking. On an unknown date, the patient had a large local reaction to PNEUMOVAX23 and a peripheral swelling as her entire arm was swelling. The patient did not undergo any laboratory test. The outcome of peripheral swelling and local reaction was recovered on an unknown date (reported as "it took a while to go away"). The reporter considered local reaction and peripheral swelling to be related to PNEUMOVAX23. Additional information has been requested.
shingles; Information has been received from a lawyer concerning a case in litigation and refers to male patient of an unknown age. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. In 2015, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, vaccination site, lot # and expiry date were not specified) for the long-term prevention of shingles and/or zoster-related conditions as prescribed and/or administered by a healthcare provider. On an unknown date, subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient has and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was unknown. The causality was related.
I gave the patient their Moderna vaccine today (5/25/23). About 20 minutes after they left, I found out that the beyond use date for the vaccine was yesterday (5/24/23). The vaccine is not expired. It has an expiration date of 6/10/23. So it was past the BUD (by one day), but not the expiration date.
Patient's mother reported patient complaining of pruritis of mouth and bilateral arms approximately 5 minutes after receiving her first dose of infant Moderna vaccine. The patient was able to speak clearly, clear throat, stick tongue out, and cough on request. Denies shortness of breath, no swelling or hives noted. Administered Benadryl liquid 6ml PO based on age and weight. Monitored patient for 30 minutes. After 30 minutes, pt denied pruritis, no further symptoms noted. Educated mother on side effects of Benadryl and instructed to follow up with Pediatrician. Mother verbalized understanding. Follow up call to mother 90 mins after incident via phone call, reports "she is doing fine with no further issues"
ACHY ARM; JOINT PAIN; HEADACHE; FATIGUE; DIARRHEA
Beginning 0200 morning after vaccination: Chills, low-grade fever (TMax 100.6 as of 1745 the day after vaccination), lethargy, nausea, headache, injection site soreness. As of 1745 the day after vaccination, nausea has subsided, but headache, fever/chills, and lethargy remain.
chills; fever; joint paint; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint paint) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint paint). At the time of the report, CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint paint) outcome was unknown.            No concomitant medications were provided by reporter. No treatment medications were reported.   This case was linked to MOD-2021-372579, MOD-2021-372818 (Patient Link).
This spontaneous report as received from a nurse refers to a 62 year old female patient with no pertinent medical history and no allergies reported. On 01-APR-2013 the patient was vaccinated with ZOSTAVAX 19400PFU (lot # J000435 and exp date 10-APR-2014). No other co suspects were reported. No concomitant therapy was reported. The nurse reported that on 20-APR-2013, the patient developed "scattered pustules across the body that look like chicken pox". The patient sought medical attention at office visit. Treatment was not given for the event. Lab diagnostics were not performed. The outcome of developed "scattered pustules across the body that look like chicken pox" was reported as not recovered/not resolved. Additional information has been requested.
Information has been received from a physician concerning a female (age unknown), who, on an unspecified date, was vaccinated with a dose of Gardasil. Subsequently, the patient experienced syncope when she was leaving the office. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested. Follow-up information indicated that the office felt that "no specific patient has a reaction directly related to Gardasil.  Additional information has been requested
This spontaneous report as received from a pharmacy technician refers to an unspecified number of patients of unknown age and gender. In approximately August 2014, the patients were vaccinated with doses of PROQUAD (Merck) (lot # not reported) that were exposed to temperatures out of range and were evaluated and supported on 15-AUG-2014 and since then administered to patients. No adverse effects were reported.This is one of several reports received from the same source. Additional information has been requested.
Had a sore arm on that weekend then on that Sunday night had a deep croupy cough went to the pediatric center and saw doctor was diagnosed with bronchitis was prescribed antibiotics and given cough medication then cough turned asthmatic and was started on albuterol breathing treatments and steroids. its been over 21days and 3 doctor visits and she is still ill she cannot participate in PE at school and is getting PRN breathing treatments there also. She is now complaining of pain on her legs arms and face and is mainly fatigue and tired .
Patient came into the clinic to receive her second dose of the Pfizer covid vaccine. Patient recieved the second dose of the Pfizer/BionTech vaccine and right after the vaccine was recived she reported excruciating pain at the time of vaccination administration  in her right deltoid. She then reported that after the vaccination she coniued to have buring sensation of the right deltoid.
Cough; Laryngitis; This case was reported by a consumer via call center representative and described the occurrence of cough in a 78-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd May 2019, the patient received Shingrix. On 4th May 2019, 1 days after receiving Shingrix, the patient experienced cough and laryngitis. On an unknown date, the outcome of the cough and laryngitis were unknown.   It was unknown if the reporter considered the cough and laryngitis to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix last Friday and next day started to cough and got laryngitis. The patient asked whether it was side effect of the shot. The patients demographic details were updated.
Constant pain in upper left arm. Physical therapy 4/24, 5/1, 5/8 and 5/17.
blurred vision, paralysis all over body. Time of occurrence was about 12:30 am 7/13/21. No treatment has been given since vaccine. Has had cuts in ligament on ankle (work related injury) the day before covid shot.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the third dose of GARDASIL. A few weeks after the third dose of GARDASIL was given, the patient had a few fainting episodes which did not occur in the office but occurred elsewhere. The reporter felt that having a few fainting episodes was not related to therapy with GARDASIL. Additional information has been requested.
Significant swelling and erythema of R arm from shoulder to below elbow, extending 1/3 to 1/2 of forearm.  Also had itching in same distribution.  Symptoms resolved after 3-4 days, took Motrin and Benadryl.
This spontaneous report as received from a healthcare worker refers to a 16 year old patient of unknown gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On 25-APR-2016 (also reported as today) the reporter stated that 16 years old patient was inadvertently vaccinated with adult dose of VAQTA 1 ml (lot # L017757 expiry date 08-APR-2018) intramuscularly in the right deltoid. No adverse effects were reported. There was no product quality complaint involved. Additional information is not expected, as the reporter did not wish further contact.
Sore arm; Muscle pain; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), MYALGIA (Muscle pain), HEADACHE (Headache) and CHILLS (Chills) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm), MYALGIA (Muscle pain), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Sore arm), MYALGIA (Muscle pain), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Patient did not have email and declined FU
Pain in shoulder starting 3 to 4 hours after vaccination continuing to date - still unresolved. Pain is severe - patient cannot lift arm to shoulder height or swing backwards.
Day of vaccine: Nausea that lasted about 6 hours. 8 days after vaccine: Site where vaccine was administered light red,itchy, warm to touch, and area was hard. Topical Benadryl cream applied to site: no longer itched. 9 days after vaccine: Site was now bright red and warm and itchy Topical Benadryl applied to site and Oral benadryl dose taken as well. 10 days after vaccine: Site light pink no longer warm or itchy
Complained of severe itching, denied pain in left arm, no rash noted.  Advised to go to Urgent Care near home this afternoon. Seen by physician at Urgent Care. Patient states she had taken a Flu vaccine 3 weeks before this Pfizer Booster Vaccine Advised by MD to take Zyrtec 10mg, 1/2 tab in the evening.  Patient feels that it was beneficial and she was able to get rest at night.
The 3rd dose of Covid 12+ vaccine that was given was not the Bivalent that is now required as the third dose.
Pfizer BioNTech COVID-19 Vaccine EUA: Patient has received five doses of vaccine. Patient received Pfizer Vaccines on 12/17/2020, 01/10/2021, 08/16/2021, 09/07/2021, and 09/21/2021.
runny nose a day or so later; little diarrhea; had a cough; post nasal drip; This is a spontaneous report from a contactable consumer (patient). This 79-year-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history included allergies and diarrhea. Concomitant medications were not reported. On an unspecified date a day or so later after receiving BNT162B2 the patient experienced a runny nose and a little diarrhea. The patient was not sure if it was from the vaccine or not. The patient also had a cough and said it could be from post nasal drip. The outcomes of runny nose, diarrhea, cough, and post nasal drip were unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
This is a spontaneous case, initially received from pharmacist on 21-Feb-2018, concerns a 64-year-old adult female patient. The patient had no medical history. The patient's concomitant medication included LIBRAX. On 04-Jan-2018, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 195124 and expiry date: 30-Apr-2018). On 21-Feb-2018, patient was again administered with second dose of FLUCELVAX QIV (in a same season). It was reported that, no adverse effects were noted after the vaccination. The reporter assessed the events as non-serious. Non-significant follow up received on 09-Apr-2018: As there is no new information in the source document, hence no changes were made in narrative.
Body Aches, Headache, Chills, Congestion, fever started on 12/18/2020 at 0300 AM Itching - right after injection given Benadryl and pepcid 15 min after the vaccination
Face red swollen rash and hives quarter size swelling at injection site within 4 hours after immunizations.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 22-OCT-2015 the patient was vaccinated with an improperly stored dose of GARDASIL 9 (0.5 ml; lot # K026247, expiration date: 29-JAN-2017; dose, frequency and route unspecified). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion 4 times. The storage criteria was refrigerator (R). The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius), Celsius conversion of the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 152, 30, -1.111111111 and R; 184, 29, 1.666666667 and R; 24, 33, 0.555555556 and R; 320, 31, -0.555555556 and R; 160, 32, 0 and R. This is one of several reports received from the same source. Additional information has been requested.
4 days post vax pt became fussy, crying, hard mass noticed lt anterolateral thigh # the time by father;no fever reported mass; 4 1/2cm x 3cm size 28APR97;some ecchymosis;no inflammation or pitting noted;
Arm started to hurt; Cheeks got bright red; in her arm she has a lump; Discomfort; Bullseye that is about 3 inches big all around; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started to hurt), ERYTHEMA (Cheeks got bright red), INJECTION SITE MASS (in her arm she has a lump), VACCINATION SITE DISCOMFORT (Discomfort) and VACCINATION SITE DISCOLOURATION (Bullseye that is about 3 inches big all around) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hurt), ERYTHEMA (Cheeks got bright red), INJECTION SITE MASS (in her arm she has a lump), VACCINATION SITE DISCOMFORT (Discomfort), VACCINATION SITE DISCOLOURATION (Bullseye that is about 3 inches big all around) and VACCINATION SITE ERYTHEMA (Redness). On 11-Jan-2021, ERYTHEMA (Cheeks got bright red) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm started to hurt), INJECTION SITE MASS (in her arm she has a lump), VACCINATION SITE DISCOMFORT (Discomfort), VACCINATION SITE DISCOLOURATION (Bullseye that is about 3 inches big all around) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient reported she put ice and took diphenhydramine for treatment but it did not make significant difference.
On June 9th I started getting hives and it was consistently every day all over my arms and legs. I saw allergist, immunologist, my PCP and  no one could determine the cause. I tried Zyrtec, Allegra, Beneryl, Doxepin all to no avail. Finally after 4 months I started acupuncture and it has been working to decrease the inflammation in my body.
Asymptomatic, patient tested at group home setting. Presented to emergency center after syncope/fall, thought to be due to dehydration
Painful armpit on the same side as injection site. When arm is in natural position, it feels like there is a rock in the armpit, and there is pain and aching. When arm is lifted, there is no significant lump, but instead a painful area when pushed. This started the day after the injection and has been increasingly painful since. Pain is continuing 48 hours after vaccination. The injection site itself is just sore as expected.
Pain at site of injection; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old adult non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm on 02Mar2021 at 13:15 (at the age of 49-years-old) for COVID-19 immunisation and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the left arm on 23Mar2021 at 13:15 (at the age of 49-years-old) for COVID-19 immunisation. The patient had no medical history. Concomitant medications included glycerine monolaurate (MONOLAURIN), vit D (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN),curcuma longa (TURMERIC CURCUMIN), all from an unknown date, for unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 02Mar2021 at 14:30, the patient experienced pain at site of injection- approximately 3 days, headache on the day of injection and fatigue. Therapeutic measures taken as a result of adverse events and treatment included with Tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain at site of injection, headache and fatigue was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
mom reports 23JAN97 pt woke up in AM crying, fussy, t104.7 R; & wouldn't eat;reports screaming/crying off & on for 23JAN & 24JAN;took to MD 23JAN97 told to go to ER if sx cont;24JAN97 to ER t103-105 R:APAP given 25JAN97 t102 R;
I had a very sore throat for 2 or 3 days and felt feverish but never had a fever. I felt achy. I took several COVID-19 home tests and always tested negative. I had my symptoms for about 6 or 7 days. I took LAGEVRIO for 5 days and felt better.
A dull to pounding headache depending on motion and light, a little tightness of breath/mucus feeling, and intense vivid dreams that night
Patient began feeling lightheaded and collapsed out of his chair. The patient did not recall falling from the chair but was conscious when attended to by the pharmacist. He had just started new medications (Lisinopril and Metformin) and had taken them in the morning prior to arriving for his vaccination. The patient did not eat anything in the morning prior to arriving for his vaccination. He was given water, a cold pack, and then orange juice. His symptoms improved and he was able to get up and walk under his own power.
Father noted swelling evening of 08/27/2003.  Left upper extremity 17 x 11.5 cm swelling, 22cm circumference, redness, mildly tender to palpation.  Orapred (15 mg/5cc) 1.5 tsp per mouth 3 times a day for 3 days.  Benadryl 2 tsp per mouth every 6 hours.
Has a compromised Immune system and has Cancer IVIG Infusions. Within 24 hours after vx started vomiting and had diarrhea with stomach pains. Called Pediatrician and was told to monitor him for hydration and fever. Then Sunday 8/14/2022 had loss of appetite, was able to eat rice and crackers. Continued diarrhea for 2 days. Sees a Neurologist and had an  appointment scheduled the day of vaccination. Labs were drawn and everything came back normal. Went to Pediatrician on 08/18/2022 and Dr said that he thinks he could have caught a virus around the time of the vaccine and that could be a contributing factor. Finally today he's been able to keep food down.